You are here

  • Home
  • Archive
  • Volume 73, Issue Suppl 2
  • OP0047 A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Proof-Of-Concept Study to Evaluate the Efficacy and Safety of Sirukumab in Patients with Active Lupus Nephritis

Article metrics

Article menu
Download PDFPDF
EULAR 2014: Scientific Abstracts
Oral Presentations. Abstract session: SLE, Sjögren's syndrome - streatment
OP0047 A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Proof-Of-Concept Study to Evaluate the Efficacy and Safety of Sirukumab in Patients with Active Lupus Nephritis

 

Online download statistics by month:

Online download statistics by month: June 2014 to February 2024

AbstractFullPdf
Jun 20141000
Jul 2014500
Aug 2014400
Sep 20141806
Oct 2014401
Nov 2014001
Dec 2014601
Jan 2015200
Feb 2015400
Mar 2015100
Apr 2015300
May 2015100
Jun 2015200
Jul 2015201
Aug 20151404
Sep 20151703
Oct 2015300
Nov 20151200
Dec 20151801
Jan 20161202
Feb 20161201
Mar 2016800
Apr 20161401
May 2016302
Jun 2016400
Jul 20161101
Aug 20162302
Sep 2016801
Oct 20161000
Nov 20161001
Dec 20161501
Jan 2017700
Feb 2017200
Mar 2017900
Apr 20171000
May 2017800
Jun 2017600
Jul 20172600
Aug 20173600
Sep 20173000
Oct 20171800
Nov 20172800
Dec 20172000
Jan 20181000
Feb 20181400
Mar 20181700
Apr 20182401
May 20182800
Jun 20183001
Jul 20182000
Aug 20182400
Sep 20181400
Oct 2018800
Nov 20181600
Dec 2018200
Jan 2019800
Feb 2019400
Mar 2019300
Apr 2019400
May 2019100
Jun 2019400
Jul 2019401
Aug 20191600
May 2020200
Jun 2020500
Jul 2020601
Aug 2020901
Sep 2020800
Oct 2020200
Nov 2020400
Dec 20201100
Jan 2021400
Apr 2021200
May 2021100
Nov 2021500
Dec 2021700
Jan 2022800
Feb 20221000
Mar 2022600
Apr 2022700
May 2022300
Jun 2022100
Jul 20221800
Aug 2022200
Sep 2022600
Oct 2022200
Nov 2022500
Dec 20222600
Feb 2023400
Mar 2023400
Apr 2023200
May 2023400
Jul 2023200
Aug 2023400
Sep 2023400
Dec 20231302
Jan 2024700
Feb 2024300
Total914037